See why Novo Nordisk A/S stock is primed for a rebound despite recent declines. Click for more about NVO growth catalysts in ...

Some experts believe, with proper precautions—and when other treatments have failed—that ketamine-assisted psychotherapy can ...

Cabotegravir was already approved for use in England and Wales as part of a combination treatment for people living with HIV.

A new way to deliver protective antibodies against COVID-19 was tested in a Phase I clinical trial. Instead of injecting ...

Sandstone Easydriptm Plus With Hextra Techtm Hexagonal Broad Hub Delivers Steadier, More Comfortable Insulin Injections. SHANGHAI, Nov. 3, 2025 /PRNewswire/ -- A peer-reviewed article by researchers ...

Third quarter revenues up 6% driven by EXPAREL volume growth of 9% -- -- Several key milestones advance 5x30 path to growth ...

Akston, the Biotech Built for Pets, in partnership with Purdue University and its College of Veterinary Medicine, announced ...

The first ever injectable drug that can prevent HIV has been approved for use in England and Wales.Authors Rosalie Hayes Research Assistant, Centre ...

PEMGARDA® (pemivibart) net product revenue of $13.1 million reported for Q3 2025, representing 41% growth year-over-year and 11% growth ...

Scientists from the University of California have warned that some ingredient combinations may not be as healthy as they seem ...

For the last several quarters, Gilead Sciences’ earnings calls have been colored by anticipation for the launch of the California drugmaker's long-acting HIV pre-exposure prophylaxis (PrEP) option. | ...